tirzepatide for the treatment of obstructive sleep apnea and obesity GLP-1 medication is known to improve apnea, but not all patients benefit equally. In a new study, presented at #ATS2026, Scott Sands, PhD, associate professor medicine at Brigham Trizepatide journal club presentation.ppt

Administered under medical guidance, our B12 injection therapy delivers this essential vitamin directly into the bloodstream for optimal absorption

Foundayo (Orforglipron) Approved in April 2026, Foundayo stands as the newest in the FDA-approved roster

Of the 14,348 participants who attended visit 2, we excluded participants who were missing measurement of HbA 1c ( n =247), had a non-fasting blood draw ( n =197), had missing data for adjustment covariates ( n =88), had prevalent diabetes (glucose-lowering medication use, HbA 1c 6.5%, or FG 7.0 mmol/l) ( n =2401), had prevalent outcomes of interest ( n =1001) or were missing information on outcomes during follow-up ( n =47)

"We thought that removing glucagon would impair insulin secretion by disrupting alpha-to-beta cell signaling," Campbell said

Stem Cell Reports 5(6):988995